The Business of Weight-Loss Drugs

How do weight-loss drugs like Ozempic and Mounjaro work? Dr. Florencia Halperin, Form Health chief medical officer, discusses the sustainability of these drugs, their efficacy against obesity and how telehealth companies can regulate their distribution.
Wall Street Journal
/
February 21, 2024
Recent press
Fierce Healthcare
Form Health, the National Leader in Science-Based Total Weight and Cardiometabolic Care, Named a “Fierce 15” Company of 2025
Business Wire
Form Health, the National Leader in Science-Based Obesity Care, Launches New Program To Prevent Progression from Overweight to Obesity

Boston, MA, February 21, 2024 - Form Health Chief Medical Officer Florencia Halperin spoke at the The Wall Street Journal Health Forum in a session titled "The Business of Weight-Loss Drugs Like Ozempic and Mounjaro". Dr. Halperin and Wall Street Journal writer Betsy McKay discussed the role of GLP-1s as part of comprehensive obesity treatment and how telehealth can expand access to high quality obesity care. Watch the entire conversation here.

‍